Abstract
The differential diagnosis of hilar cholangiocarcinoma (HCCA) that include primary malignancies, metastatic disease and benign lesions is challenging and presents a diagnostic dilemma in surgery. Generally, biliary tumors are accompanied by painless jaundice with evidence of biliary obstruction [1, 2]. Currently, this presentation by itself is usually enough to raise a strong suspicion of neoplastic biliary obstruction. The clinical findings and laboratory values including tumor markers are non-specific and cannot correctly identify the exact cause of the stricture. Thus, preoperative differential diagnosis, which is desirable to confirm surgical indication and to advise patients about the disease and their respective prognosis, is extremely difficult. Although the assessment of patients with obstructive jaundice has greatly improved by the currently available noninvasive, and invasive imaging modalities, all these techniques cannot always be relied upon to provide a definitive diagnosis, in particular in the absence of a visible tumor mass [3]. In addition, it is well known that not all hilar obstructions are due to HCCA and alternative diagnosis that mimic HCCA may count for up to 25 % of all hilar obstructions [4–7]. Benign strictures for example, occasionally manifest as focal areas of wall thickening that obstruct the lumen and, thus, mimic malignant strictures. Approximately 16 % (range, 3.4–58.6 %) of patients initially diagnosed with hilar cholangiocarcinoma proved to have a benign stricture [3–20]. Biopsy is so often nondiagnostic that decisions about therapy are usually made on the basis of the imaging tests and lack of evidence for some other disease [3, 4, 21–26]. Although specific radiographic features, such as absence of tumor mass, smooth concentric pattern or tapering of the bile duct, can be associated with benign lesions, none can unequivocally exclude the presence of malignancy [6]. As a result, differentiating HCCA related biliary obstructions (Fig. 9.1) from obstructions caused by other malignant (Figs. 9.2 and 9.3) and benign (Figs. 9.4 and 9.5) lesions remains a challenge. Because the majority of biliary strictures at the liver hilum in the absence of previous surgery are usually malignant in nature and presumed to be due to HCCA, a reasonable approach is to assume the presence of HCCA until proved otherwise [15, 27–29]. However, surgeons should always be aware of the possibility of other disease particularly a benign disease and advise their patients appropriately. The diagnosis is much less specific than is generally thought, so there is considerable opportunity for mismanaging such patients. Although it has always been clear that basing the diagnosis on indirect evidence would occasionally be incorrect, a 25 % rate of false diagnosis by a team of highly specialized clinicians who encounter many such complicated cases is higher than most would have expected. Alternative diagnosis with proximal biliary obstruction mimicking HCCA is present in such a proportion of patients that it really deserves a place in the differential diagnosis of biliary obstruction. Differentiating HCCA from other causes of obstructive jaundice is important because of the differences in treatment. Curative surgical therapy for HCCA requires bile duct resection with concomitant major hepatectomy and caudate lobe resection or neoadjuvant chemoradiation, followed by liver transplantation in highly selected patients [30, 31]. This type of surgery is generally not necessary for benign conditions and generally not warranted for metastatic or other non-HCCA malignancies. Thus, preoperative precise characterization of obstructive jaundice due to hilar obstruction has important clinical implications. It would potentially improve planning for surgery and may prevent subjecting some patients to major and risky surgical interventions unnecessarily.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ohsawa M, Aosaza K, Horiuchi K, et al. Malignant lymphoma of the liver: report of 5 cases and review of the litrature. Dig Dis Sci. 1992;37:1105–9.
Eliason SC, Grosso LE. Primary biliary malignant lymphoma clinically mimicking cholangiocarcinoma: a case report and review of the literature. Ann Diagn Pathol. 2001;5:25–33.
Principe A, Ercolani G, Bassi F, et al. Diagnostic dilemmas in biliary strictures mimicking cholangiocarcinoma. Hepatogastroenterology. 2003;50:1246–9.
Hadjis NS, Collier NA, Blumgart LH. Malignant masquerade at the hilum of the liver. Br J Surg. 1985;72:659–61.
Wetter LA, Ring EJ, Pellegrini CA, et al. Differential diagnosis of sclerosing cholangiocarcinomas of the common hepatic duct (Klatskin tumors). Am J Surg. 1991;161:57–63.
Gerhards MF, Vos P, van Gulik TM, et al. Incidence of benign lesions in patients resected for suspicious hilar obstruction. Br J Surg. 2001;88:48–51.
Koea J, Holden A, Chau K, et al. Differential diagnosis of stenosing lesions at the hepatic hilus. World J Surg. 2004;28:466–70.
Standfield NJ, Salsbury JR, Howard ER. Benign non-traumatic inflammatory strictures of the extrahepatic biliary system. Br J Surg. 1989;76:849–52.
Verbeek PCM, van Leeuwen DJ, de Wit LT, et al. Benign fibrosing disease at the hepatic confluence mimicking Klatskin tumors. Surgery. 1992;112:866–71.
Nakayama A, Imamura H, Shimada R, et al. Proximal bile duct stricture disguised as malignant neoplasm. Surgery. 1999;125:514–25.
Knoefel WT, Prenzel KL, Peiper M, et al. Klatskint tumors and Klatskin mimicking lesions of the biliary tree. Eur J Surg Oncol. 2003;29:658–61.
Park MS, Kim TK, Kim KW, et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology. 2004;233:234–40.
Corvera CU, Blumgart LH, Darvishian H, et al. Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma. J Am Coll Surg. 2005;201:862–9.
Uhlmann D, Wiedmann M, Schmidt F, et al. Management and outcome in patients with Klatskin-mimicking lesions of the biliary tree. J Gastrointest Surg. 2006;10:1144–50.
Are C, Gonen M, DÁngelica M, et al. Differential diagnosis of proximal biliary obstruction. Surgery. 2006;140:756–63.
Saluja SS, Sharma R, Paul S, et al. Differentiation between benign and malignant hilar obstructions using laboratory and radiological investigations: a prospective study. HPB. 2007;9:373–82.
Kloek JJ, van Delden OM, Erdogan D, et al. Differentiation of malignant and benign proximal bile duct strictures: the diagnostic dilemma. World J Gastroenterol. 2008;14:5032–8.
Erdogan D, Kloek JJ, ten Kate FJW, et al. Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures. Br J Surg. 2008;95:727–34.
te Boekhorst DS, Gerhards MF, van Gulik TM, et al. Granular cell tumor at the hepatic duct confluence mimicking Klatskin tumor. Dig Surg. 2000;17:299–303.
Binkley CE, Eckhauser FE, Colleti LM. Unusual cases of benign biliary strictures with cholangiographic features of cholangiocarcinoma. J Gastrointest Surg. 2002;6:676–81.
Harell GS, Anderson MF, Berry PF. Cytologic bile examination in the diagnosis of biliary duct neoplastic strictures. Am J Roentgenol. 1981;137:1123–6.
Evander A, Ihse I, Lunderquist A, et al. Percutaneous cytodiagnosis of carcinoma of the pancreas and bile duct. Ann Surg. 1978;188:90–2.
Cohan RH, Illscas FF, Newman GE, et al. Biliary cytodiagnosis. Bile sampling for cytology. Invest Radiol. 1985;20:177–9.
Ponchon T, Gagnon P, Berger F, et al. Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: results of a prospective study. Gastrointest Endosc. 1995;42:565–72.
van Gulik TM, Reeders JW, Bosma A, et al. Incidence and clinical findings of benign inflammatory disease in patients resected for presumed pancreatic head cancer. Gastrointest Endosc. 1997;46:417–23.
Andersson R, Andren-Sandberg A, Lundstedt C, et al. Implantation metastasis from gastrointestinal cancer after percutaneous puncture or biliary drainage. Eur J Surg. 1996;162:551–4.
Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med. 1965;38:241–56.
Longmire Jr WP, McArthur MS. The management of extrahepatic bile duct carcinoma. Jpn J Surg. 1973;3:1–8.
Cameron JL, Broe P, Zuidema GD. Proximal bile duct tumors: surgical management with silastic transhepatic biliary stents. Ann Surg. 1982;196:412–9.
Rea DJ, Heimback JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg. 2005;242:451–61.
Ito F, Cho CS, Rikkers LF, et al. Hilar cholangiocarcinoma: current management. Ann Surg. 2009;250:210–8.
Perpetuo MD, Valdivieso M, Heilbrun LK, et al. Natural history study of gallbladder cancer. A review of 36 years experience at MD Anderson Hospital and Tumor Institute. Cancer. 1978;42:330–5.
De Groen PC, Gores GJ, LaRusso NF, et al. Biliary tract cancers. N Engl J Med. 1999;341:1368–78.
Menias CO, Surabhi VR, Prasad SR, et al. Mimics of cholangiocarcinoma: spectrum of disease. Radiographics. 2008;28:1115–29.
Dasgupta T, Brasfield R. Metastasic melanoma: a clinicopathologic study. Cancer. 1964;15:1323–39.
Medina V, Darnell A, Bejarano N, et al. Primary biliary tract malignant melanoma: US, CT, and MR findings. Abdom Imaging. 2003;28:842–6.
El Rassi ZS, Mohsine RM, Berger F, et al. Endocrine tumors of the extrahepatic bile ducts: pathological and clinical aspects, surgical management and outcome. Hepatogastroenterology. 2004;51:1295–300.
Penna C, Nordlinger B. Surgery and local treatments of liver metastases from colorectal cancer: how to improve results. Scand J Surg. 2003;92:90–6.
Saha S, Bardelli A, Buckhaults P, et al. A phosphatase associated with metastasis of colorectal cancer. Science. 2001;294:1343–6.
Jatzko GR, Lisborg PH, Stettner HM, et al. Hepatic resection for metastases from colorectal carcinoma: a survival analysis. Eur J Cancer. 1995;31A:41–6.
Riopel MA, Klimstra DS, Godellas CV, et al. Intrabiliary growth of metastatic colonic adenocarcinoma: a pattern of intrahepatic spread easily confused with primary neoplasia of the biliary tract. Am J Surg Pathol. 1997;21:1030–6.
Rivindra KV, Stringer MD, Prasad KR, et al. Non-Hodgkin lymphoma presenting with obstructive jaundice. Br J Surg. 2003;90:845–9.
Das K, Fisher A, Wilson DJ, et al. Primary non-Hodgkin’s lymphoma of the bile ducts mimicking cholangiocarcinoma. Surgery. 2003;134:496–500.
Brouland JP, Molimard J, Nemeth J, et al. Primary T-cell rich B-cell lymphoma of the common bile duct. Virchows Arch A Pathol Anat Histopathol. 1993;423:513–7.
Van Slyck EJ, Schuman BM. Lymphocytic lymphosarcoma of the gallbladder. Cancer. 1972;30:810–6.
Nguyen GK. Primary extranodal non-Hodgkin’s lymphoma of the extrahepatic bile ducts. Report of a case. Cancer. 1982;50:2218–22.
Page RD, Romaguera JE, Osborne B, et al. Primary hepatic lymphoma: favorable outcome after combination chemotherapy. Cancer. 2001;92:2023–9.
Chapman RWG, Arborgh BAM, Rohdes JM, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut. 1980;21:870–7.
Thompson HH, Pitt HA, Tompkins RK, et al. Primary sclerosing cholangitis: a heterogeneous disease. Ann Surg. 1982;196:127–36.
Broome U, Olsson R, Loof L, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut. 1996;38:610–5.
Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004;24:115–25.
LaRussso NF, Shneider BL, Black D, et al. Primary sclerosing cholangitis: summary of a workshop. Hepatology. 2006;44:746–64.
Burak K, Angulo P, Pasha TM, et al. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol. 2004;99:523–6.
Pitt HA, Dooley WC, Yeo CJ, et al. Malignancies of the biliary tree. Curr Probl Surg. 1995;32:1–90.
Bergquist A, Glaumann H, Persson B, et al. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology. 1998;27:311–6.
Abdalian R, Heathcote EJ. Sclerosing cholangitis: a focus on secondary causes. Hepatology. 2006;44:1063–74.
Buc E, Lesurtel M, Belghiti J. Is preoperative histological diagnosis necessary before referral to major surgery for cholangiocarcinoma? HPB. 2008;10:98–105.
Sasahira N, Kawabe T, Nakamura A, et al. Inflammatory pseudotumor of the liver and peripheral eosinophilia in autoimmune pancreatitis. World J Gastroenterol. 2005;11:922–5.
Coffin CM, Hamphrey PA, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey. Semin Diagn Pathol. 1998;15:85–101.
Nonomura A, Minato H, Shimizu K, et al. Hepatic hilar inflammatory pseudotumor mimicking cholangiocarcinoma with cholangitis and phlebitis: a variant of primary sclerosing cholangitis? Pathol Res Pract. 1997;193:519–25.
Amankonah TD, Strom CB, Vierling JM, et al. Inflammatory pseudotumor of the liver as the first manifestation of Chrohn’s disease. Am J Gastroenterol. 2001;96:2520–2.
Horiuchi R, Uchida T, Kojima T, et al. Inflammatory pseudotumor of the liver. Clinicopathological study and review of the literature. Cancer. 1990;65:1583–90.
Pack GT, Baker HW. Total right hepatic lobectomy; reports of a case. Ann Surg. 1953;138:253–8.
Yan FH, Zhou KR, Jiang YP, et al. Inflammatory pseudotumor of the liver: 13 cases of MRI findings. World J Gastroenterol. 2001;7:422–4.
Tublin ME, Moser AJ, Marsh JW, et al. Biliary inflammatory pseudotumor: imaging features in seven patients. AJR Am J Roentgenol. 2007;188:W44–8.
Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28:1193–203.
Nakayma F, Solowa RD, Nakama T, et al. Hepatolithiasis in East Asia. Retrospective study. Dig Dis Sci. 1986;31:21–6.
Harris HW, Kumwenda ZL, Sheen-Chen S. Recurrent pyogenic cholangitis. Am J Surg. 1998;176:34–7.
Seel DJ, Park YK. Oriental inflectional cholangitis. Am J Surg. 1983;146:366–70.
Lim JH. Oriental cholagiohepatitis: pathologic, clinical, and radiologic features. AJR Am J Roentgenol. 1991;157:1–8.
RM S, Koch J, Sandhu JS, et al. Recurrent pyogenic cholangitis in Asian immigrants to the United States: natural history and role of therapeutic ERCP. Dig Dis Sci. 1997;42:865–71.
Reynolds WR, Brinkman JD, Haney BD, et al. Oriental cholangiohepatitis. Mil Med. 1994;159:158–60.
Park MS, Yu JS, Kim KW, et al. Recurrent pyogenic cholangitis: comparison between MR cholangiography and direct cholangiography. Radiology. 2001;220:677–82.
Kim MJ, Cha SW, Mitchel DJ, et al. MR imaging findings in recurrent pyogenic cholangitis. AJR Am J Roentgenol. 1999;173:1545–9.
Lim JH, Ko YT, Lee DH, et al. Oriental cholangiohepatitis: sonographic findings in 48 cases. AJR Am J Roentgenol. 1990;155:511–4.
Chan FL, Man SW, Leong LL, et al. Evaluation of recurrent pyogenic cholangitis with CT: analysis of 50 patients. Radiology. 1989;170:165–9.
Coppel MS. Hepatobiliary manifestations of the acquired immune deficiency syndrome. Am J Gastroenterol. 1991;86:1–15.
Cello JP. Human immunodeficiency virus associated biliary tract disease. Semin Liver Dis. 1992;12:213–28.
Margulis SJ, Honig CL, Soave R, et al. Biliary tract obstruction in the acquired immunodeficiency syndrome. Ann Intern Med. 1986;105:207–10.
Bouche H, Housset C, Dumont JL. AIDS-related cholangitis: diagnostic features and course in 15 patients. J Hepatol. 1993;17:34–9.
Dolmatch BL, Laing FC, Ferderle MP, et al. AIDS-related cholangitis: radiographic findings in 9 patients. Radiology. 1987;163:313–6.
Cello JP, Chan MF. Long-term follow up of endoscopic retrograde cholangiopancreatography sphincterotomy for patients with acquired immune deficiency syndrome papillary stenosis. Am J Med. 1995;99:600–3.
Nash JA, Cohen SA. Gallbladder and biliary tract disease in AIDS. Gastroenterol Clin North Am. 1997;26:323–35.
Pol S, Romana CA, Richard S, et al. Microsporadia infection in patients with the human immunodeficiency virus and unexplained cholangitis. N Engl J Med. 1993;328:95–9.
Finkelberg DL, Sahani D, Deshpande V, et al. Autoimmune pancreatitis. N Engl J Med. 2006;355:2670–6.
Krasinskas AM, Raina A, Khalid A, et al. Autoimmune pancreatitis. Gastroenterol Clin North Am. 2007;36:239–57.
Ectors N, Maillet B, Aerts R, et al. Non-alcoholic duct destructive chronic pancreatitis. Gut. 1997;41:263–8.
Kim KP, Kim MH, Song MH, et al. Autoimmune chronic pancreatitis. Am J Gastroenterol. 2004;99:1605–16.
Pearson RK, Longnecker DS, Chari ST, et al. Controversy in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas. 2003;27:1–13.
Kamisawa T, Egawa N, Nakajima H, et al. Clinical difficulties in the differentiation of autoimmune pancreatitis and pancreatic carcinoma. Am J Gastroenterol. 2003;98:2694–9.
Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38:982–4.
Sarin SK, Bhatia B, Makawane U. Portal biliopathy in extrahepatic portal vein obstruction. Indian J Gastroenterol. 1992;2:A82.
Sarin SK, Agarwal SR. Extrahepatic portal vein obstruction. Semin Liver Dis. 2002;22:43–58.
Dumortier J, Vaillant E, Boillot O, et al. Diagnosis and treatment of biliary obstruction caused by portal cavernoma. Endoscopy. 2003;35:446–50.
Condat B, Vilgrian V, Asselah T, et al. Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study. Hepatology. 2003;37:1302–8.
Shin SM, Kim S, Lee JW, et al. Biliary abnormalities associated with portal biliopathy: evaluation on MR cholangiography. Am J Roentgenol. 2007;188:W341–7.
Bayrakatar Y, Balkanci F, Kayhan B, et al. Bile duct varices or “pseudocholangiocarcinoma sign” in portal hypertension due to cavernous transformation of the portal vein. Am J Gastroenterol. 1992;87:1801–6.
Mirizzi PL. Sindrome del conducto hepatico. J Int Chir. 1948;8:731–7.
Csendes A, Diaz JC, Burdiles P, et al. Mirizzi syndrome and cholecystobiliary fistula: a unifying classification. Br J Surg. 1989;76:1139–43.
Johnson LW, Sehon JK, Lee WC, et al. Mirizzi’s syndrome: experience from a multi-institutional review. Am Surg. 2001;67:11–4.
Lai ECH, Lau WY. Mirizzi syndrome: history, present and future development. ANZ J Surg. 2006;76:251–7.
Baer HU, Matthews JB, Schweizer WP, et al. Management of the Mirizzi syndrome and the surgical implication of cholecystocholedochal fistula. Br J Surg. 1990;77:743–5.
Becker CD, Hassler H, Terrier F. Preoperative diagnosis of the Mirizzi syndrome: limitations of sonography and computed tomography. AJR Am J Roentgenol. 1984;143:591–6.
Kunisaki SM, Hertl M, Bodner BE, et al. Mirizzi syndrome secondary to an adenoma of the cystic duct. J Hepatobiliary Pancreat Surg. 2005;12:159–62.
Loh A, Kamar S, Dickson GH. Solitary benign papilloma (papillary adenoma) of the cystic duct: a rare cause of biliary colic. Br J Clin Pract. 1994;48:167–8.
Satoh H, Hirano T, Ogawa Y, et al. Adenoma arising from the cystic duct and extending to the confluence of the extrahepatic biliary tract. J Hepatobiliary Pancreat Surg. 1999;6:186–9.
Allaire GS, Rabin L, Ishak KG, et al. Bile duct adenoma. A study of 152 cases. Am J Surg Pathol. 1988;12:708–15.
Kawakatsu M, Vilgrain V, Zins M, et al. Radiologic features of papillary adenoma and papilomatosis of the biliary tract. Abdom Imaging. 1997;22:87–90.
Buckley JG, Salimi Z. Villous adenoma of the common bile duct. Abdom Imaging. 1993;18:245–6.
Jennings PE, Rode J, Coral A, et al. Villous adenoma of the common hepatic duct: the role of ultrasound in management. Gut. 1990;31:558–60.
Burhans R, Meyers RT. Benign neoplasms of the extrahepatic biliary ducts. Am Surg. 1971;37:161–6.
Cox CE, Davis-Allen A, Judson MA. Sarcoidosis. Med Clin North Am. 2005;89:817–28.
Judson MA. Extrapulmonary sarcoidosis. Semin Respir Crit Care Med. 2007;28:83–101.
Pungpapong S, Steers JL, Wallace MB, et al. Hepatobiliary sarcoidosis mimicking Klatskin’s cholangiocarcinoma. Gastrointest Endosc. 2006;64:124–5.
Ishak KG. Sarcoidosis of the liver and bile ducts. Mayo Clin Proc. 1998;73:467–72.
Alam I, Levenson SD, Ferrell LD, et al. Diffuse intrahepatic biliary strictures in sarcoidosis resembling sclerosing cholangitis. Case report and review of the literature. Dig Dis Sci. 1997;42:1295–301.
Howard TJ, Bennion RS, Thompson Jr JE. Xanthogranulomatous cholecystitis: a chronic inflammatory pseudotumor of the gallbladder. Am Surg. 1991;57:821–4.
Kwon AH, Matsui Y, Uemura Y. Surgical procedures and histopathologic findings for patients with xanthogranulomatous cholecystitis. J Am Coll Surg. 2004;199:204–10.
Dixit VK, Prakash A, Gupta A, et al. Xanthogranulomatous cholecystitis. Dig Dis Sci. 1998;43:940–2.
Benbow EW. Xanthogranulomatous cholecystitis. Br J Surg. 1990;77:255–6.
Shuto R, Kiyosue H, Komatsu E, et al. CT and MR imaging findings of xanthogranulomatous cholecystitis: correlation with pathologic findings. Eur Radiol. 2004;14:440–6.
Kawate S, Ohawada S, Ikota H, et al. Xanthogranulomatous cholangitis causing obstructive jaundice: a case report. World J Gastroenterol. 2006;12:4428–30.
Krishna RP, Kumar A, Singh RK, et al. Xanthogranulomatous inflammatory strictures of extrahepatic biliary tract: presentation and surgical management. J Gastrointest Surg. 2008;12:836–41.
Batts KP. Ischemic cholangitis. Mayo Clin Proc. 1998;73:380–5.
Alazmi WM, McHenry L, Watkins JL, et al. Chemotherapy-induced sclerosing cholangitis: long-term response to endoscopic therapy. J Clin Gastroenterol. 2006;40:353–7.
Barnett KT, Malafa MP. Complications of hepatic artery infusion: a review of 4580 reported cases. Int J Gastrointest Cancer. 2001;30:147–60.
Lorenz M, Muller HH. Randomized multicenter trial of fluorouracil plus leucoverin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with non-resectable liver metastases from colorectal carcinoma. J Clin Oncol. 2000;18:243–54.
Martin RC, Edwards MJ, McMasters KM. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver. Am J Surg. 2004;188:714–21.
Kerr DJ, McArdle SC, Ledermann J, et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicenter randomized trial. Lancet. 2003;361:368–73.
Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med. 1999;341:2039–48.
Hohn D, Melnick J, Stagg R, et al. Biliary sclerosis in patients receiving hepatic arterial infusion of floxuridine. J Clin Oncol. 1985;3:98–102.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht and People's Medical Publishing House
About this chapter
Cite this chapter
Kassahun, W., Stumpp, P., Hoffmeister, A., Jonas, S. (2013). Differential Diagnosis. In: Lau, W. (eds) Hilar Cholangiocarcinoma. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6473-6_9
Download citation
DOI: https://doi.org/10.1007/978-94-007-6473-6_9
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6472-9
Online ISBN: 978-94-007-6473-6
eBook Packages: MedicineMedicine (R0)